Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,096
Closed -$266K 324
2022
Q1
$266K Sell
1,096
-457
-29% -$111K 0.02% 277
2021
Q4
$405K Sell
1,553
-280
-15% -$72.7K 0.03% 226
2021
Q3
$483K Hold
1,833
0.03% 205
2021
Q2
$452K Sell
1,833
-523
-22% -$110K 0.03% 202
2021
Q1
$457K Buy
2,356
+350
+17% +$70.2K 0.03% 197
2020
Q4
$426K Sell
2,006
-128
-6% -$25.5K 0.03% 196
2020
Q3
$366K Buy
2,134
+9
+0.4% +$1.66K 0.03% 197
2020
Q2
$408K Sell
2,125
-165
-7% -$27K 0.04% 185
2020
Q1
$337K Buy
2,290
+41
+2% +$6.53K 0.03% 196
2019
Q4
$349K Sell
2,249
-54
-2% -$7.78K 0.03% 215
2019
Q3
$300K Sell
2,303
-150
-6% -$19.7K 0.03% 226
2019
Q2
$299K Buy
2,453
+27
+1% +$2.99K 0.03% 203
2019
Q1
$252K Sell
2,426
-63
-3% -$6.5K 0.03% 209
2018
Q4
$283K Sell
2,489
-205
-8% -$22K 0.03% 190
2018
Q3
$311K Buy
2,694
+18
+0.7% +$1.97K 0.04% 180
2018
Q2
$277K Sell
2,676
-408
-13% -$41.3K 0.04% 175
2018
Q1
$304K Buy
+3,084
New +$291K 0.04% 172

Other funds holding RMD

Rockland Trust's RMD Position: Q2 2022 in Review

Rockland Trust sold out of ResMed (RMD) in Q2 2022, closing a stake of 1,096 shares — an estimated $266K sold.

Rockland Trust first reported a position in RMD in Q1 2018 and held it in 17 quarters. The position peaked at $483K in Q3 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Rockland Trust reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Rockland Trust sold 1,096 ResMed shares in Q2 2022, an estimated $266K.
  • Rockland Trust first reported a position in ResMed in Q1 2018 and held it in 17 quarters.
  • Rockland Trust's ResMed position peaked at $483K in Q3 2021.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Rockland Trust's 13F filing for Q2 2022, filed 13 Jul 2022.